Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

News | Heart Failure

January 13, 2021 — FineHeart, a preclinical-stage medical device company developing a novel left ventricular assist ...

Home January 13, 2021
Home
News

December 29, 2020 — Here is a list of the top 10 news stories from the European Society of Cardiology (ESC) in 2020 that ...

Home December 29, 2020
Home
News | Heart Failure

December 21, 2020 — U.S. Food and Drug Administration (FDA) approved updated labeling December 17 for Abbott's HeartMate ...

Home December 21, 2020
Home
News | Coronavirus (COVID-19)

December 2, 2020 — A 2-month-old infant diagnosed with COVID-19 (SARS-CoV-2) experienced reversible myocardial injury ...

Home December 02, 2020
Home
News | Heart Failure

December 2, 2020 — The Centers for Medicare and Medicaid Services (CMS) finalized updates to Medicare coverage policies ...

Home December 02, 2020
Home
News | Coronavirus (COVID-19) | Dave Fornell, Editor

November 18, 2020 — A late-breaking study at the 2020 American Heart Association (AHA) Scientific Sessions showed nearly ...

Home November 18, 2020
Home
Some of the device technologies discussed in the TCT 2020 late-breaking trial sessions. Top left, the  Medtronic Resolute Onyx stent was the first stent to receive FDA clearance for short duration dual-antiplatelet therapy, which was a big topic and subject of several sessions. Lower left, the Keystone TriGuard 3 TAVR embolic protection device did not demonstrate superiority over TAVR without use of embolic protection. Top right, the Abbott MitraClip. Acurate neo TAVR valve. #TCTconnect #TCT2020
Feature | TCT | Dave Fornell, Editor

Here are some of the key takeaways from the late-breaking interventional cardiology and structural heart trials ...

Home October 29, 2020
Home
Videos | Heart Failure

The late-breaking MitraBridge Study was presented at Transcatheter Cardiovascular Therapeutics (TCT) 2020 meeting showed ...

Home October 16, 2020
Home
News | Coronavirus (COVID-19)

October 14, 2020 — American College of Cardiology (ACC) Quality Summit virtual meeting Oct. 8-9, 2020, featured several ...

Home October 14, 2020
Home
Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.
Feature | Udi Nussinovitch M.D., Ph.D.

This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...

Home October 09, 2020
Home
News | Heart Valve Technology

October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...

Home October 02, 2020
Home
News | Heart Failure

September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN) ...

Home September 23, 2020
Home
News | Coronavirus (COVID-19)

September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...

Home September 08, 2020
Home
Navin Kapur, M.D., FAHA, FACC, FSCAI, executive director, The CardioVascular Center for Research and Innovation (CVCRI), explains the concpet of the Door-to-Unloading (DTU) Trial he is heading, one of several innovations at Tufts Medical Center in Boston. Kapur is also director, Acute Mechanical Circulatory Support Program; director, interventional research laboratories; director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI), Tufts Medical Center. Photo by Dave Fornell
Feature | Tufts Medical Center | Dave Fornell, Editor

The cardiology program at Tufts Medical Center in Boston is internationally recognized for being on the forefront of ...

Home August 21, 2020
Home
Subscribe Now